A systematic review of the clinical significance of pulmonary Mycobacterium kansasii isolates in HIV infection

Journal of Acquired Immune Deficiency Syndromes

Volumn 36, Issue 4, 2004, Pages 883-889

  Marras, Theodore K ^a   Daley, Charles L ^b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atypical; Diagnosis; Guidelines; HIV; Mycobacterium infections; Mycobacterium kansasii; Practice guidelines

Indexed keywords

BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATION; DIAGNOSTIC VALUE; DRUG ABUSE; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM KANSASII; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SURVIVAL; T LYMPHOCYTE;

ANTITUBERCULAR AGENTS; CARRIER STATE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM KANSASII; PRACTICE GUIDELINES; SUBSTANCE ABUSE, INTRAVENOUS; TUBERCULOSIS, PULMONARY;

EID: 3242726837     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200408010-00001     Document Type: Review

References (22)

1. Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med. 2002;23:553-567.
2. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156: S1-S25.
3. Levine B, Chaisson RE. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection. Ann Intern Med. 1991;114:861-868.
4. Valainis GT, Cardona LM, Greer DL. The spectrum of Mycobacterium kansasii disease associated with HIV-1 infected patients. J Acquir Immune Defic Syndr. 1991;4:516-520.
5. Witzig RS, Fazal BA, Mera RM, et al. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1. Clin Infect Dis. 1995;21:77-85.
6. Corbett EL, Blumberg L, Churchyard GJ, et al. Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners. Am J Respir Crit Care Med. 1999;160:15-21.
7. Rooney G, Nelson MR, Gazzard B. Mycobacterium kansasii: its presentation, treatment and outcome in HIV infected patients. J Clin Pathol. 1996;49:821-823.
8. Spradling P, Drociuk D, McLaughlin S, et al. Drug-drug interactions in inmates treated for human immunodeficiency virus and Mycobacterium tuberculosis infection or disease: an institutional tuberculosis outbreak. Clin Infect Dis. 2002;35:1106-1112.
9. Burman WJ, Gallicano K, Peloquin C. Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis. Clin Infect Dis. 1999;28:419-429.
10. Bamberger DM, Driks MR, Gupta MR, et al. Mycobacterium kansasii among patients infected with human immunodeficiency virus in Kansas City. Clin Infect Dis. 1994;18:395-400.
11. Bloch KC, Zwerling L, Pletcher MJ, et al. Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. Ann Intern Med. 1998;129:698-704.
12. Campo RE, Campo CE. Mycobacterium kansasii disease in patients infected with human immunodeficiency virus. Clin Infect Dis. 1997;24:1233-1238.
13. Carpenter JL, Parks JM. Mycobacterium kansasii infections in patients positive for human immunodeficiency virus. Rev. Infect Dis. 1991;13:789-796.
14. Corbett EL, Churchyard GJ, Hay M, et al. The impact of HIV infection on Mycobacterium kansasii disease in South African gold miners. Am J Respir Crit Care Med. 1999;160:10-14.
15. Corbett EL, Churchyard GJ, Clayton TC, et al. HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners. AIDS. 2000;14:2759-2768.
16. Fishman JE, Schwartz DS, Sais GJ. Mycobacterium kansasii pulmonary infection in patients with AIDS: spectrum of chest radiographic findings. Radiology. 1997;204:171-175.
17. Klein JL, Corbett EL, Slade PM, et al. Mycobacterium kansasii and human immunodeficiency virus co-infection in London. J Infect. 1998;37:252-259.
18. Lortholary O, Deniel F, Boudon P, et al. Mycobacterium kansasii infection in a Paris suburb: comparison of disease presentation and outcome according to human immunodeficiency virus status. Int J Tuberc Lung Dis. 1999;3:68-73.
19. Pintado V, Gomez-Mampaso E, Martin-Davila P, et al. Mycobacterium kansasii infection in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis. 1999;18:582-586.
20. Santin M, Alcaide F. Mycobacterium kansasii disease among patients infected with human immunodeficiency virus type 1: improved prognosis in the era of highly active antiretroviral therapy. Int J Tuberc Lung Dis. 2003;7:673-677.
21. Griffith DE. Management of disease due to Mycobacterium kansasii. Clin Chest Med. 2002;23:613-622.
22. Jones D, Havlir DV. Nontuberculous mycobacteria in the HIV infected patient. Clin Chest Med. 2002;23:665-674.